Market Place
Sourcing Support
Guardant Health to Report Q1 2026 Results on May 7
16 Apr 2026 //
BUSINESSWIRE
Guardant InfinityAI Supports ENHERTU Approval Japan
30 Mar 2026 //
BUSINESSWIRE
Verana & Guardant Health Partner For Precision Medicine
24 Mar 2026 //
PR NEWSWIRE
Guardant Health To Present 28 Abstracts Highlighting Advances
18 Mar 2026 //
BUSSINESSWIRE
Guardant Health Awards Inducement Grants Under Nasdaq Rule
27 Feb 2026 //
BUSINESSWIRE
Guardant Health Reveals 2025 Financials, Offers 2026 Outlook
19 Feb 2026 //
BUSINESSWIRE
Guardant Health To Participate In Upcoming Investor Conferences
03 Feb 2026 //
BUSINESSWIRE
Guardant Health to Report Q4, FY 2025 Results Feb. 19
29 Jan 2026 //
BUSINESSWIRE
Guardant Health, Merck Partner To Develop Cancer Therapies
19 Jan 2026 //
BUSINESSWIRE
Guardant Health Reveals 2025 Q4 And Full-Year Results
11 Jan 2026 //
BUSINESSWIRE
Guardant Health Joins 44Th J.P. Morgan Healthcare Conference
29 Dec 2025 //
BUSINESSWIRE
Global Healthy Living & Guardant Health Announce Partnership
29 Dec 2025 //
BUSINESSWIRE
Guardant Health, Trial Library Partner to Boost U.S. Cancer
11 Dec 2025 //
BUSINESSWIRE
Guardant Health To Participate In Upcoming Investor Conferences
07 Nov 2025 //
BUSINESSWIRE
Guardant Health Reveals Inducement Grants Per Nasdaq LR
06 Nov 2025 //
BUSINESSWIRE
Guardant Health Prices $350M Convertible Senior Notes Offering
05 Nov 2025 //
BUSINESSWIRE
Guardant Health Prices Increased Public Stock Offering
05 Nov 2025 //
BUSINESSWIRE
Guardant Health Plans $300M Convertible Senior Notes Offering
04 Nov 2025 //
BUSINESSWIRE
Guardant Health Announces Proposed Public Offering of Stock
04 Nov 2025 //
BUSINESSWIRE
Guardant Health Boosts 2025 Revenue Forecast After Q3 Financials
29 Oct 2025 //
BUSINESSWIRE
Guardant Health To Present Blood-Based Testing Impact On Cancer
26 Oct 2025 //
BUSINESSWIRE
Guardant Health, Collaborators To Unveil Cancer Care Data
15 Oct 2025 //
BUSINESSWIRE
Guardant Health To Release Q3 2025 Financial Results On October
09 Oct 2025 //
BUSINESSWIRE
Alex M. Azar II Appointed to Guardant Health Board
15 Sep 2025 //
BUSINESSWIRE
Guardant Health Updates Clinical Data on Colorectal Cancer Test
04 Sep 2025 //
BUSINESSWIRE
Guardant Health to Host Investor Day on September 24, 2025
28 Aug 2025 //
BUSINESSWIRE
Guardant Health Announces Inducement Grants Under Rule 5635(c)(4)
15 Aug 2025 //
BUSINESSWIRE
Guardant Health to Join Canaccord Genuity 45th Growth Conference
31 Jul 2025 //
BUSINESSWIRE
Guardant Health Raises 2025 Guidance, Shares Q2 Update
30 Jul 2025 //
BUSINESSWIRE
Guardant Health to Report Q2 2025 Financial Results on July 30
14 Jul 2025 //
BUSINESSWIRE
Bay Area Lyme Foundation Announces New Executive Director Wein
18 Jun 2025 //
GLOBENEWSWIRE
Guardant Adds Smart Liquid Biopsy Apps for Guardant360
27 May 2025 //
BUSINESSWIRE
Guardant Health Introduces Hereditary Cancer Testing
20 May 2025 //
BUSINESSWIRE
Guardant Health to Participate in Upcoming Investor Conferences
08 May 2025 //
BUSINESSWIRE
Guardant Health Announces Inducement Grants Under Nasdaq Listing
07 May 2025 //
BUSINESSWIRE
Guardant Health Reports Q1 2025 Results, 2025 Revenue Guidance
30 Apr 2025 //
BUSINESSWIRE
Guardant Health Shows Shield Test Performance Across 10 Tumors
29 Apr 2025 //
BUSINESSWIRE
Guardant Health to Present Advances in Multi-Cancer Detection
22 Apr 2025 //
BUSINESSWIRE
Guardant Health to Report Q1 2025 Financial Results on April 30
10 Apr 2025 //
BUSINESSWIRE
Guardant Health to Participate in Upcoming Investor Conferences
10 Feb 2025 //
BUSINESSWIRE
Guardant Health to Report Q4 & Full Year Financial Results
30 Jan 2025 //
BUSINESSWIRE
Guardant Health’s Shield Test Chosen For Cancer Screening
30 Jan 2025 //
BUSINESSWIRE
Guardant Presents Data On Precision Oncology Tools At ASCO GI
23 Jan 2025 //
BUSINESSWIRE
Guardant Health Announces Preliminary Q4 & Full Year 2024 Results
13 Jan 2025 //
BUSINESSWIRE
Guardant Health To Report Q3 2024 Financial Results On November 6
15 Oct 2024 //
BUSINESSWIRE
Guardant Health to Participate in Upcoming Investor Conferences
08 Aug 2024 //
BUSINESSWIRE
FDA Approves Guardant Health`s Shield™ Blood Test For CRC Screening
29 Jul 2024 //
BUSINESSWIRE
Guardant`s Blood Cancer Test Nears Medicare Coverage With FDA Approval
29 Jul 2024 //
REUTERS
Guardant Health to Participate in Upcoming Investor Conferences
22 May 2024 //
BUSINESSWIRE
US FDA staff says Guardant`s test may fail to detect some pre-cancerous tumors
22 May 2024 //
REUTERS
Guardant Gets EU IVDR Cert For Guardant360 CDx Liquid Biopsy
21 May 2024 //
BUSINESSWIRE
Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
17 May 2024 //
BUSINESSWIRE
Guardant Health Q1 2024 Results, Increases 2024 Revenue Guidance
09 May 2024 //
BUSINESSWIRE
Guardant Health Surpasses 500 Peer-Reviewed Publications Milestone
07 May 2024 //
BUSINESSWIRE
Guardant Health to Participate in Upcoming Investor Conferences
07 May 2024 //
BUSINESSWIRE
Guardant Health to Report First Quarter 2024 Financial Results on May 9, 2024
18 Apr 2024 //
BUSINESSWIRE
Guardant Health Reports Fourth Quarter and Full Year 2023 Financial Results
22 Feb 2024 //
BUSINESSWIRE
Guardant Health to Participate in Upcoming Investor Conferences
15 Feb 2024 //
BUSINESSWIRE
Guardant Health to Report Fourth Quarter and Full Year 2023 Financial Results
01 Feb 2024 //
BUSINESSWIRE
Guardant Health and Hikma Partner to Offer Cancer Screening Tests
08 Jan 2024 //
BUSINESSWIRE
